Journal Article

Blocking Ubiquitin‐Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl‐CoA Desaturase

Yu, Wenkai, Qin, Jiang‐Jiang, Dai, Enyu, Miao, Kai, Cheng, Xiang‐Dong, Lu, Yang, Guan, Xiaoqing, Zhao, Bing, Hu, Can, Yuan, Li, Wang, Yichao, Luan, Xin, Zhang, Weidong, Wei, Yong, Chen, Bonan, Dong, Xiaowu

2024

Overview

Gastric cancer (GC) presents a formidable global health challenge, and conventional therapies face efficacy limitations. Ubiquitin‐specific protease 7 (USP7) plays pivotal roles in GC development, immune response, and chemo‐resistance, making it a promising target. Various USP7 inhibitors have shown selectivity and efficacy in preclinical studies. However, the mechanistic role of USP7 has not been fully elucidated, and currently, no USP7 inhibitors have been approved for clinical use. In this study, DHPO is identified as a potent USP7 inhibitor for GC treatment through in silico screening. DHPO demonstrates significant anti‐tumor activity in vitro, inhibiting cell viability and clonogenic ability, and preventing tumor migration and invasion. In vivo studies using orthotopic gastric tumor mouse models validate DHPO's efficacy in suppressing tumor growth and metastasis without significant toxicity. Mechanistically, DHPO inhibition triggers ferroptosis, evidenced by mitochondrial alterations, lipid Reactive Oxygen Species (ROS), Malondialdehyde (MDA) accumulation, and iron overload. Further investigations unveil USP7's regulation of Stearoyl‐CoA Desaturase (SCD) through deubiquitination, linking USP7 inhibition to SCD degradation and ferroptosis induction. Overall, this study identifies USP7 as a key player in ferroptosis of GC, elucidates DHPO's inhibitory mechanisms, and highlights its potential for GC treatment by inducing ferroptosis through SCD regulation. A novel Ubiquitin‐Specific Protease 7 (USP7) inhibitor, DHPO, is identified through in silico screening for gastric cancer (GC) treatment. DHPO demonstrates robust anti‐tumor effects, inducing ferroptosis and effectively suppressing GC growth and metastasis both in vitro and in vivo. Mechanistically, USP7 triggers ferroptosis by targeting Stearoyl‐CoA Desaturase (SCD).

• Publisher: John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
• Subject: Animals / Blood vessels / Cancer therapies / Cell Line, Tumor / Disease Models, Animal / Enzymes / ferroptosis / Ferroptosis - drug effects / Ferroptosis - genetics / Gastric cancer / Humans / Immunotherapy / Labeling / Ligands / Medical prognosis / Mice / Proteins / SCD / Software / Stearoyl-CoA Desaturase - genetics / Stearoyl-CoA Desaturase - metabolism / Stomach Neoplasms - drug therapy / Stomach Neoplasms - genetics / Stomach Neoplasms - metabolism / Stomach Neoplasms - pathology / Ubiquitin-Specific Peptidase 7 - genetics / Ubiquitin-Specific Peptidase 7 - metabolism / ubiquitination / USP7 / USP7 inhibitor